✦ LIBER ✦

CV5: ORLISTAT IN OBESE TYPE 2 DIABETIC PATIENTS: ASSESSMENT OF LONG TERM OUTCOMES AND COST-EFFECTIVENESS

✍ Scribed by M Lamotte; LJ Annemans; A Lefever; M Nechelput; J Masure

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Orlistat in responding obese type 2 diab

✍ Ruof, J; Golay, A; Berne, C; Collin, C; Lentz, J; Maetzel, A 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Long-term effect of metformin on blood g

✍ Hiroyuki Ito; Hidenori Ishida; Yuichiro Takeuchi; Shinichi Antoku; Mariko Abe; M 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 963 KB

Long-term benefits of complementary insu

✍ Rudolf Chlup; Helena Vaverková; Josef Bartek 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Psychological determinants of compliance

✍ Klara Nurymberg; Shulamith Kreitler 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Cost-effectiveness of exenatide versus i

✍ Gordon Goodall; María Costi; Louise Timlin; Jesús Reviriego; José Antonio Sacris 📂 Article 📅 2011 🏛 Elsevier ⚖ 225 KB

CV3 LONG-TERM COSTS AND CLINICAL CONSEQU

✍ AJ Palmer; S Roze; V Foos; FM Lurati; S Hirini 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB